Literature DB >> 9203698

Unimmunized Gypsy populations and implications for the eradication of poliomyelitis in Europe.

R B Aylward1, D Porta, L Fiore, B Ridolfi, P Chierchini, F Forastiere.   

Abstract

The certification of poliomyelitis eradication in Europe will eventually require that countries demonstrate there is a minimal risk of wild poliovirus reintroduction and sustained transmission through unimmunized subpopulations such as ethnic minorities. A serologic survey among a Gypsy community in Italy found that despite only 26% documented immunization coverage, serum neutralizing antibodies to poliovirus types 1, 2, and 3 were detected in 81%, 94%, and 63% of the 86 persons studied. While the high level of immunity found in this community may have been due to secondary spread of vaccine virus, the possibility of unrecognized circulation of wild polioviruses cannot be excluded. Targeted immunization of such groups may be the most efficient means of eliminating the risk of importation-associated outbreaks.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203698     DOI: 10.1093/infdis/175.supplement_1.s86

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  The health of the Roma people: a review of the published literature.

Authors:  S Hajioff; M McKee
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

2.  Enterovirus surveillance of Italian healthy children.

Authors:  A M Patti; A L Santi; L Fiore; L Vellucci; D De Stefano; E Bellelli; S Barbuti; G M Fara
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.

Authors:  Chen-Fu Yang; Tary Naguib; Su-Ju Yang; Eman Nasr; Jaume Jorba; Nahed Ahmed; Ray Campagnoli; Harrie van der Avoort; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Mark Pallansch; Olen Kew
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  Surveillance of acute flaccid paralysis in Italy: 1996-1997. AFP Study Group. Acute flaccid paralysis.

Authors:  L Fiore; F Novello; P Simeoni; C Amato; L Vellucci; D De Stefano; M E Grandolfo; I Luzzi
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

5.  Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.

Authors:  Dongmei Yan; Li Li; Shuangli Zhu; Yong Zhang; Junjing An; Dongyan Wang; Ning Wen; Jaume Jorba; Wei Liu; Ge Zhong; Lin Huang; Olen Kew; Xiaofeng Liang; Wenbo Xu
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

6.  Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.

Authors:  Cara C Burns; Jing Shaw; Jaume Jorba; David Bukbuk; Festus Adu; Nicksy Gumede; Muhammed Ali Pate; Emmanuel Ade Abanida; Alex Gasasira; Jane Iber; Qi Chen; Annelet Vincent; Paul Chenoweth; Elizabeth Henderson; Kathleen Wannemuehler; Asif Naeem; Rifqiyah Nur Umami; Yorihiro Nishimura; Hiroyuki Shimizu; Marycelin Baba; Adekunle Adeniji; A J Williams; David R Kilpatrick; M Steven Oberste; Steven G Wassilak; Oyewale Tomori; Mark A Pallansch; Olen Kew
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 7.  The final stages of the global eradication of poliomyelitis.

Authors:  Nicholas C Grassly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

8.  Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.

Authors:  Mala Rakoto-Andrianarivelo; Sophie Guillot; Jane Iber; Jean Balanant; Bruno Blondel; Franck Riquet; Javier Martin; Olen Kew; Bakolalao Randriamanalina; Lalatiana Razafinimpiasa; Dominique Rousset; Francis Delpeyroux
Journal:  PLoS Pathog       Date:  2007-12       Impact factor: 6.823

9.  Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings.

Authors:  Rui Fu; Jonathan Altamirano; Clea C Sarnquist; Yvonne A Maldonado; Jason R Andrews
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.